schizophrenia
The test detects blood gene expression biomarkers that are predictive of high hallucination and high delusion states and future hospitalizations.
Multigene PGx Testing Improves Outcomes for Schizophrenia Patients, Randomized Study Shows
A study comparing Chinese patients who received therapy guided by genetic testing and those who got standard care showed better outcomes for those in the PGx arm.
Saladax Biomedical, Beckman Coulter Partner to Distribute Antipsychotic Drug Tests
Saladax's laboratory assays measure drug levels of antipsychotic drugs prescribed to treat patients with mental illnesses.
The researchers at the Royal College of Surgeons Ireland recently received €1.3 million from Wellcome Trust to support the development of the blood-based test.
Saladax Biomedical Receives FDA De Novo Clearance for Antipsychotic Drug Assay
The firm said that together with other clinical findings, the test can help manage patients prescribed clozapine for treatment-resistant schizophrenia.
May 18, 2018
Mar 21, 2018